151 related articles for article (PubMed ID: 6596562)
1. Aspartame--a review.
Waggoner WF
Pediatr Dent; 1984 Sep; 6(3):153-8. PubMed ID: 6596562
[No Abstract] [Full Text] [Related]
2. Aspartame. Review of safety issues. Council on Scientific Affairs.
JAMA; 1985 Jul; 254(3):400-2. PubMed ID: 2861297
[TBL] [Abstract][Full Text] [Related]
3. The safety of aspartame.
Pardridge WM
JAMA; 1986 Nov; 256(19):2678. PubMed ID: 3773174
[No Abstract] [Full Text] [Related]
4. How sweet is it?
Briggs TA
Dent Abstr; 1985 Feb; 30(2):76-8. PubMed ID: 3855765
[No Abstract] [Full Text] [Related]
5. Decision on Aspartame due this year.
Holden C
Science; 1980 Feb; 207(4433):856-7. PubMed ID: 7355267
[No Abstract] [Full Text] [Related]
6. Use of aspartame in phenylketonuric heteroxygous adults.
Koch R; Shaw KN; Williamson M; Haber M
J Toxicol Environ Health; 1976 Nov; 2(2):453-7. PubMed ID: 796477
[TBL] [Abstract][Full Text] [Related]
7. [Aspartame: a sweetening agent with a high phenylalanine content].
Bickel H; Trefz FK
Monatsschr Kinderheilkd; 1986 Jul; 134(7):478-80. PubMed ID: 3748044
[No Abstract] [Full Text] [Related]
8. Results of loading doses of aspartame by two phenylketonuric (PKU) children compared with two normal children.
Koch R; Schaeffler G; Shaw NF
J Toxicol Environ Health; 1976 Nov; 2(2):459-69. PubMed ID: 1011297
[TBL] [Abstract][Full Text] [Related]
9. Synthetic sweetners: cyclamates, saccharin, aspartame.
Med Lett Drugs Ther; 1975 Jul; 17(15):61-2. PubMed ID: 1152816
[No Abstract] [Full Text] [Related]
10. Consumption of aspartame by heterozygotes for phenylketonuria.
Freedman M
J Pediatr; 1987 Apr; 110(4):662-3. PubMed ID: 3559821
[No Abstract] [Full Text] [Related]
11. Effects of aspartame and phenylalanine on meal-time food intake of humans.
Anderson GH; Leiter LA
Appetite; 1988; 11 Suppl 1():48-53. PubMed ID: 3056266
[TBL] [Abstract][Full Text] [Related]
12. Aspartame and PKU.
Wenz E
J Am Diet Assoc; 1984 Jan; 84(1):101. PubMed ID: 6690561
[No Abstract] [Full Text] [Related]
13. Aspartame and other sweeteners.
Med Lett Drugs Ther; 1982 Jan; 24(600):1-2. PubMed ID: 7054648
[No Abstract] [Full Text] [Related]
14. Aspartame may imperil dietary control of phenylketonuria.
Güttler F; Lou H
Lancet; 1985 Mar; 1(8427):525-6. PubMed ID: 2857893
[No Abstract] [Full Text] [Related]
15. Possible neurologic effects of aspartame, a widely used food additive.
Maher TJ; Wurtman RJ
Environ Health Perspect; 1987 Nov; 75():53-7. PubMed ID: 3319565
[TBL] [Abstract][Full Text] [Related]
16. Effects of oral aspartame on plasma phenylalanine in humans and experimental rodents. Short note.
Wurtman RJ; Maher TJ
J Neural Transm; 1987; 70(1-2):169-73. PubMed ID: 3668518
[TBL] [Abstract][Full Text] [Related]
17. Plasma amino acid levels after single-dose aspartame consumption in phenylketonuria, mild hyperphenylalaninemia, and heterozygous state for phenylketonuria.
Caballero B; Mahon BE; Rohr FJ; Levy HL; Wurtman RJ
J Pediatr; 1986 Oct; 109(4):668-71. PubMed ID: 3761084
[No Abstract] [Full Text] [Related]
18. Use of aspartame by apparently healthy children and adolescents.
Frey GH
J Toxicol Environ Health; 1976 Nov; 2(2):401-15. PubMed ID: 137987
[TBL] [Abstract][Full Text] [Related]
19. The safety of aspartame.
JAMA; 1987 Jul; 258(2):205-6. PubMed ID: 3599303
[No Abstract] [Full Text] [Related]
20. Aspartame: review of recent experimental and observational data.
Janssen PJ; van der Heijden CA
Toxicology; 1988 Jun; 50(1):1-26. PubMed ID: 3291200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
